39 results
8-K
EX-4.2
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
as Stockholder Until Exercise; No Settlement in Cash. This Preferred Investment Option does not entitle the Holder to any voting rights, dividends
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
8-K
EX-4.2
o6ktgt15 geux
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
qqhdu
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.1
8uilppra zyjch8f8p7
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.3
tfxfum7fo28w3d
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
0555m9
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
s76l0 fr5httt
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
kc2fbsiraw1j 8y6rlgc
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
du5lngr9p0p7ha8zy
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
5rfpi6coeis
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
h34x1e5wirnd 9v
25 Apr 22
Prospectus supplement
5:02pm
424B3
se4uz1ax6d2j3boo 4b
7 Apr 22
Prospectus supplement
4:46pm
S-3
me90n14 xh5d9k
4 Feb 22
Shelf registration
4:36pm
DEF 14A
ek2oh2l xlgnmaymh
28 Oct 21
Definitive proxy
3:07pm